Navigation Links
Thoratec Reports Second Quarter Revenue Increase of 17 Percent
Date:8/3/2011

ross margin on a non-GAAP basis

69.00%70.00%Operating expenses growth For the Fiscal Year Ended 2011 FromTo Increase in operating expense on a GAAP basis

17.00%19.00%Share-based compensation expense

-1.00%-1.00%Amortization of intangibles

-0.70%-0.70%Levitronix transaction costs

-0.30%-0.30% Increase in operating expense on a non-GAAP basis

15.00%17.00%Net income per diluted share reconciliation For the Fiscal Year Ended 2011 FromToNet income per diluted share on a GAAP basis

$
.05$
.15Share-based compensation expense

0.180.18Amortization of purchased intangibles

0.090.09Impact of adoption of ASC 470-20

0.030.03Levitronix transaction costs

0.040.04Income tax effect of non-GAAP income before tax

0.010.01Net income per diluted share on a non-GAAP basis

$
.40$
.50Shares used  in calculation of net income per diluted share --GAAP and non-GAAP

63,00063,000Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate LVAS and Thoratec VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web site at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Levitronix Medical GmbH, which is being renamed as Thoratec Switzerland GmbH in connection with the transaction.

Many of the preceding paragraphs, particularly but not exclusively those addressing guidance for fiscal 2011 financial results or future performance, contain forward-looking statements within the meaning of Secti
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Thoratec Announces Resignation of Chief Financial Officer
2. Thoratec Announces Presentations at Upcoming Investor Conferences
3. Thoratec Announces Development Agreement With WiTricity for Proprietary Energy Transfer Technology
4. Thoratec Presentation at Bank of America Conference to be Webcast
5. Thoratec Reports First Quarter 2011 Results
6. Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034
7. Thoratec Announces Presentations at Upcoming Investor Conferences
8. Thoratec Corporation Authorizes $100 Million Share Repurchase Program
9. Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
10. Thoratec Schedules Fourth Quarter Conference Call, Webcast
11. Thoratec Presentation at J.P. Morgan Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients ... to a recent online survey* sponsored by Mission Pharmacal ... the National Osteoporosis Foundation online support community, revealed that ... medication that comes in a form other than a ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... CITY, Feb. 21, 2012 Genomma Lab Internacional, S.A.B. de ... a non-binding proposal to acquire all of the outstanding shares ... ) common stock for $16.60 dollars per share in cash. ... including Prestige,s net debt. Genomma,s all-cash proposal ...
... Corporation (NYSE: SHP ) ("ShangPharma" or the ... development outsourcing company, today announced that it will attend ... in Boston, Massachusetts from March 5-7, 2012. ... Relations of ShangPharma, will present at the conference and ...
Cached Medicine Technology:Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 2Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 3Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 4Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 5
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... University synthetic biology team has created a new ... therapeutics that could travel the body and selectively ... Engineering cell-based, biological devices that monitor and modify ... synthetic biology. However, no existing technology enabled bioengineers ... physiological state and respond in a customized fashion. ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease is ... may be mistaken for foreign invaders and killed by ... autoimmune diseases like type I diabetes, celiac disease, and ... published April 16, 2014, in Nature Communications . ... in Parkinson,s disease; but if true, it could lead ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2
... , ... ... ... ...
... are beginning to find out why people with Parkinson,s ... harder to recognize expressions of emotion in other people,s ... American Psychological Association. One of the studies raises ... treatment for patients who no longer respond to medication, ...
... ... Innovative Set of Sales and Lead Cycle Management Technology , ... (PRWEB) March 3, 2010 -- References-Online, pioneer and leader in ... RO|Innovation (ROI). The name and brand identity shift reflects the expanded suite of ...
... , ... ... ... ...
... ... ... , ... , , ...
... already shown to be effective in breast cancer packs an ... have a specific genetic mutation, a study at UCLA,s Jonsson ... Tykerb when given together proved to significantly inhibit tumor growth ... a mutation that results in an aggressive form of the ...
Cached Medicine News:Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:Parkinson's disease makes it harder to figure out how other people feel 2Health News:Parkinson's disease makes it harder to figure out how other people feel 3Health News:Embodying an Evolving Solution Set, References-Online is Now RO|Innovation 2Health News:Embodying an Evolving Solution Set, References-Online is Now RO|Innovation 3Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 2Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 3Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 4Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 5Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 6Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 7Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 8Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 9Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 10Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 11Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 12Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 13Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 14Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 15Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 16Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 2Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 3Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 4Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 5Health News:Herceptin and Tykerb effective against a subset of gastric cancers 2Health News:Herceptin and Tykerb effective against a subset of gastric cancers 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: